Green tea polyphenols reduce body weight in rats by modulating obesity-related genes

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Lu, Chuanwen ^a   Zhu, Wenbin ^a   Shen, Chwan Li ^b   Gao, Weimin ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CATECHOL METHYLTRANSFERASE; COPPER ZINC SUPEROXIDE DISMUTASE; ESTROGEN; GREEN TEA POLYPHENOL; INTERLEUKIN 1BETA; INTERLEUKIN 6; RNA; UNCLASSIFIED DRUG; FAT INTAKE; POLYPHENOL; TEA;

ADCYAP1R1 GENE; ADRB1 GENE; AGRP GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOA4 GENE; APPETITE; ARTICLE; CNTF GENE; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GHR GENE; GHRL GENE; HORMONE ACTION; IL 1BETA GENE; INS1 GENE; LEPR GENE; LIVER; NONHUMAN; NR3C1 GENE; OBESITY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; RNA EXTRACTION; SORT GENE; TEA; WEIGHT REDUCTION; ANIMAL; BODY WEIGHT; CAMELLIA SINENSIS; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; FAT INTAKE; GENE EXPRESSION REGULATION; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BODY WEIGHT; CAMELLIA SINENSIS; DIETARY FATS; FEMALE; GENE EXPRESSION REGULATION; OBESITY; POLYPHENOLS; RATS; RATS, SPRAGUE-DAWLEY; TEA;

EID: 84862002340     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038332     Document Type: Article

References (88)

1. Weight-control Information Network website. Available:http://win.niddk.nih.gov/statistics/#overweight. Accessed: 2012 May 10.
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ, (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625 1638.
3. Must A, Spadano J, Coakley EH, Field AE, Colditz G, (1999) The disease burden associated with overweight and obesity. JAMA 282: 1523 1529.
4. Spiegelman BM, Flier JS, (2001) Obesity and the regulation of energy balance. Cell 104: 531 543.
5. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, (2006) The human obesity gene map: the 2005 update. Obesity 14: 529 644.
6. Auvichayapat P, Prapochanung M, Tunkamnerdthai O, Sripanidkulchai BO, Auvichayapat N, (2008) Effectiveness of green tea on weight reduction in obese Thais: A randomized, controlled trial. Physiol Behav 93: 486 491.
7. Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, (2008) Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 27: 363 370.
8. Lonac MC, Richards JC, Schweder MM, Johnson TK, Bell C, (2011) Influence of short-term consumption of the caffeine-free, epigallocatechin-3-gallate supplement, Teavigo, on resting metabolism and the thermic effect of feeding. Obesity (Silver Spring) 19: 298 304.
9. Nagao T, Hase T, Tokimitsu I, (2007) A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) 15: 1473 1483.
10. Phung OJ, Baker WL, Matthews LJ, Lanosa M, Thorne A, (2010) Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr 91: 73 81.
11. Stendell-Hollis NR, Thomson CA, Thompson PA, Bea JW, Cussler EC, (2010) Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors. J Hum Nutr Diet 23: 590 600.
12. Wang H, Wen Y, Du Y, Yan X, Guo H, (2010) Effects of catechin enriched green tea on body composition. Obesity (Silver Spring) 18: 773 779.
13. Westerterp-Plantenga MS, (2010) Green tea catechins, caffeine and body-weight regulation. Physiol Behav 100: 42 46.
14. Basu A, Sanchez K, Leyva MJ, Wu M, Betts NM, (2010) Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr 29: 31 40.
15. Boschmann M, Thielecke F, (2007) The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: a pilot study. J Am Coll Nutr 26: 389S 395S.
16. Rains TM, Agarwal S, Maki KC, (2011) Antiobesity effects of green tea catechins: a mechanistic review. J Nutr Biochem 22: 1 7.
17. Shen CL, Yeh JK, Samathanam C, Cao JJ, Stoecker BJ, (2011) Green tea polyphenols attenuate deterioration of bone microarchitecture in female rats with systemic chronic inflammation. Osteoporos Int 22: 327 337.
18. Shen CL, Yeh JK, Cao JJ, Tatum OL, Dagda RY, (2010) Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model. J Nutr Biochem 21: 968 974.
19. Shen CL, Yeh JK, Stoecker BJ, Chyu MC, Wang JS, (2009) Green tea polyphenols mitigate deterioration of bone microarchitecture in middle-aged female rats. Bone 44: 684 690.
20. Shao C, Chen L, Lu C, Shen CL, Gao W, (2011) A gel-based proteomic analysis of the effects of green tea polyphenols on ovariectomized rats. Nutrition 27: 681 686.
21. Shen CL, Yeh JK, Cao JJ, Chyu MC, Wang JS, (2011) Green tea and bone health: Evidence from laboratory studies. Pharmacol Res 64: 155 161.
22. Shen CL, Wang P, Guerrieri J, Yeh JK, Wang JS, (2008) Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int 19: 979 990.
23. Shao C, Lu C, Chen L, Koty PP, Cobos E, (2011) p53-Dependent anticancer effects of leptomycin B on lung adenocarcinoma. Cancer Chemother Pharmacol 67: 1369 1380.
24. Khan NI, Naz L, Yasmeen G, (2006) Obesity: an independent risk factor for systemic oxidative stress. Pak J Pharm Sci 19: 62 65.
25. Jequier E, (2002) Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 967: 379 388.
26. Dulloo AG, (2002) Biomedicine. A sympathetic defense against obesity. Science 297: 780 781.
27. Buettner R, Scholmerich J, Bollheimer LC, (2007) High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 15: 798 808.
28. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL, (2001) Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 37: 554 560.
29. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278: 135 138.
30. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, (1997) Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 11: 593 602.
31. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656 660.
32. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50: 707 709.
33. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50: 1714 1719.
34. Rosmond R, (2003) Association studies of genetic polymorphisms in central obesity: a critical review. International journal of obesity 27: 1141 1151.
35. Boullu-Ciocca S, Paulmyer-Lacroix O, Fina F, Ouafik L, Alessi MC, (2003) Expression of the mRNAs coding for the glucocorticoid receptor isoforms in obesity. Obes Res 11: 925 929.
36. Bronnegard M, Reynisdottir S, Marcus C, Stierna P, Arner P, (1995) Effect of glucocorticosteroid treatment on glucocorticoid receptor expression in human adipocytes. J Clin Endocrinol Metab 80: 3608 3612.
37. Fujimoto K, Machidori H, Iwakiri R, Yamamoto K, Fujisaki J, (1993) Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity of rats. Brain Res 608: 233 237.
38. Fujimoto K, Fukagawa K, Sakata T, Tso P, (1993) Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest 91: 1830 1833.
39. Wai-man RW, Stephens JW, Acharya J, Hurel SJ, Humphries SE, (2004) The APOA4 T347S variant is associated with reduced plasma TAOS in subjects with diabetes mellitus and cardiovascular disease. Journal of lipid research 45: 1565 1571.
40. Wong WMR, Gerry AB, Putt W, Roberts JL, Weinberg RB, (2007) Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation. Atherosclerosis 192: 266 274.
41. Navab M, Hama SY, Ready ST, Ng CJ, Van Lenten BJ, (2002) Oxidized lipids as mediators of coronary heart disease. Current opinion in lipidology 13: 363 372.
42. Matthews VB, Febbraio MA, (2008) CNTF: a target therapeutic for obesity-related metabolic disease? J Mol Med (Berl) 86: 353 361.
43. Nam S, Lobie P, (2000) The mechanism of effect of growth hormone on preadipocyte and adipocyte function. obesity reviews 1: 73 86.
44. Ballesteros M, Leung KC, Ross RJM, Iismaa TP, Ho KKY, (2000) Distribution and abundance of messenger ribonucleic acid for growth hormone receptor isoforms in human tissues. Journal of Clinical Endocrinology & Metabolism 85: 2865 2871.
45. Egecioglu E, Bjursell M, Ljungberg A, Dickson SL, Kopchick JJ, (2006) Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. American Journal of Physiology-Endocrinology And Metabolism 290: E317 E325.
46. Erman A, Wabitsch M, Goodyer C, (2011) Human growth hormone receptor (GHR) expression in obesity: II. Regulation of the human GHR gene by obesity-related factors. International journal of obesity. 35(12): 1520 1529.
47. Kahn BB, Flier JS, (2000) Obesity and insulin resistance. Journal of Clinical Investigation 106: 473 481.
48. Brennan AM, Mantzoros CS, (2006) Drug Insight: the role of leptin in human physiology and pathophysiology-emerging clinical applications. Nat Clin Pract Endocrinol Metab 2: 318 327.
49. Houseknecht KL, Baile CA, Matteri RL, Spurlock ME, (1998) The biology of leptin: a review. J Anim Sci 76: 1405 1420.
50. Houseknecht KL, Portocarrero CP, (1998) Leptin and its receptors: regulators of whole-body energy homeostasis. Domest Anim Endocrinol 15: 457 475.
51. Brabant G, Muller G, Horn R, Anderwald C, Roden M, (2005) Hepatic leptin signaling in obesity. FASEB J 19: 1048 1050.
52. Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, (2010) From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466: 714 719.
53. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707 713.
54. Elekes K, Sandor K, Moricz A, Kereskai L, Kemeny A, (2011) Pituitary adenylate cyclase-activating polypeptide plays an anti-inflammatory role in endotoxin-induced airway inflammation: in vivo study with gene-deleted mice. Peptides 32: 1439 1446.
55. Garfield AS, Lam DD, Marston OJ, Przydzial MJ, Heisler LK, (2009) Role of central melanocortin pathways in energy homeostasis. Trends in Endocrinology & Metabolism 20: 203 215.
56. Gjesing A, Andersen G, Albrechtsen A, Glümer C, Borch Johnsen K, (2007) Studies of associations between the Arg389Gly polymorphism of the 1 adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects. Diabetic medicine 24: 392 397.
57. Rumpler W, Seale J, Clevidence B, Judd J, Wiley E, (2001) Oolong tea increases metabolic rate and fat oxidation in men. J Nutr 131: 2848 2852.
58. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, (1999) Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 70: 1040 1045.
59. Chantre P, Lairon D, (2002) Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine 9: 3 8.
60. Choo JJ, (2003) Green tea reduces body fat accretion caused by high-fat diet in rats through beta-adrenoceptor activation of thermogenesis in brown adipose tissue. J Nutr Biochem 14: 671 676.
61. Yudkin JS, Stehouwer C, Emeis J, Coppack S, (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology 19: 972 978.
62. Festa A, D'Agostino Jr R, Williams K, Karter A, Mayer-Davis E, (2001) The relation of body fat mass and distribution to markers of chronic inflammation. International journal of obesity 25: 1407 1415.
63. Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, (2004) The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 14: 589 600.
64. Matsuki T, Horai R, Sudo K, Iwakura Y, (2003) IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med 198: 877 888.
65. Bondia-Pons I, Ryan L, Martinez JA, (2012) Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem. [Epub ahead of print].
66. Moon HS, Lee HG, Choi YJ, Kim TG, Cho CS, (2007) Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity. Chem Biol Interact 167: 85 98.
67. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752 1761.
68. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, (2003) Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23: 434 439.
69. Wolfram S, Wang Y, Thielecke F, (2006) Anti-obesity effects of green tea: from bedside to bench. Mol Nutr Food Res 50: 176 187.
70. Pico C, Puigserver P, Oliver P, Palou A, (1998) 2-Methoxyestradiol, an endogenous metabolite of 17beta-estradiol, inhibits adipocyte proliferation. Mol Cell Biochem 189: 1 7.
71. Berrino F, Bellati C, Secreto G, Camerini E, Pala V, (2001) Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev 10: 25 33.
72. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET, (2002) Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105: 564 569.
73. Wang SS, Morton LM, Bergen AW, Lan EZ, Chatterjee N, (2007) Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial. Hum Genet 122: 41 49.
74. Genecards website. Available:http://www.genecards.org. Accessed: 2012 May 10.
75. Mitscher LA, Jung M, Shankel D, Dou JH, Steele L, (1997) Chemoprotection: a review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituents. Med Res Rev 17: 327 365.
76. Kao YH, Hiipakka RA, Liao S, (2000) Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141: 980 987.
77. Matsumoto N, Ishigaki F, Ishigaki A, Iwashina H, Hara Y, (1993) Reduction of blood glucose levels by tea catechin. Bioscience, biotechnology, and biochemistry 57: 525 527.
78. Klaus S, Pültz S, Thöne-Reineke C, Wolfram S, (2005) Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond) 29: 615 623.
79. Murase T, Nagasawa A, Suzuki J, Hase T, Tokimitsu I, (2002) Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord 26: 1459 1464.
80. Borchardt RT, Huber JA, (1975) Catechol O-methyltransferase. 5. Structure-activity relationships for inhibition by flavonoids. J Med Chem 18: 120 122.
81. Belza A, Toubro S, Astrup A, (2009) The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake. Eur J Clin Nutr 63: 57 64.
82. Belza A, Frandsen E, Kondrup J, (2007) Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects. Int J Obes (Lond) 31: 121 130.
83. Hsu TF, Kusumoto A, Abe K, Hosoda K, Kiso Y, (2006) Polyphenol-enriched oolong tea increases fecal lipid excretion. Eur J Clin Nutr 60: 1330 1336.
84. Chan CC, Koo MW, Ng EH, Tang OS, Yeung WS, (2006) Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome-a randomized placebo-controlled trial. J Soc Gynecol Investig 13: 63 68.
85. Fukino Y, Shimbo M, Aoki N, Okubo T, Iso H, (2005) Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol (Tokyo) 51: 335 342.
86. Diepvens K, Kovacs EM, Vogels N, Westerterp-Plantenga MS, (2006) Metabolic effects of green tea and of phases of weight loss. Physiol Behav 87: 185 191.
87. Hill AM, Coates AM, Buckley JD, Ross R, Thielecke F, (2007) Can EGCG reduce abdominal fat in obese subjects? J Am Coll Nutr 26: 396S 402S.
88. Maki KC, Reeves MS, Farmer M, Yasunaga K, Matsuo N, (2009) Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr 139: 264 270.